特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
946925

クレアチンキナーゼの世界市場規模:タイプ(MM、BB、MB、MiMi)、用途、地域別予測

Global Creatine Kinase Market Size study by Type (MM, BB, MB, MiMi), by Application (Hospital, Laboratory, Others) and Regional Forecasts 2020-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
クレアチンキナーゼの世界市場規模:タイプ(MM、BB、MB、MiMi)、用途、地域別予測
出版日: 2020年06月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のクレアチンキナーゼ市場は、心筋梗塞に苦しむ患者数の増加、有利な償還シナリオ、ヘルスケア費用と資金調達の増加は、予測期間中の同市場の高い成長率を推進する要因です。また、クレアチンキナーゼ検査を強化するための新規クレアチンキナーゼ試薬の急速な発売は、世界市場の成長をさらに加速させています。ただし、一部の先進国と新興国での製品承認に関する不利な規制ガイドラインは、予測期間中の市場成長を抑制する要因の1つとなっています。

当レポートは世界のクレアチンキナーゼ市場について調査しており、市場機会や動向、成長要因および課題、タイプ・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場定義および調査範囲

第3章 市場力学

  • 市場の影響分析

第4章 業界分析

  • ポーターのファイブフォース分析
  • PEST分析
  • 投資採用モデル
  • アナリストの提言と結論

第5章 市場分析:タイプ別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場推計・予測
  • サブセグメント分析
    • MM
    • BB
    • MB
    • MiMi

第6章 市場分析:用途別

  • 市場のスナップショット
  • 市場実績:ポテンシャル分析
  • 市場推計・予測
  • サブセグメント分析
    • 病院
    • 研究室
    • その他

第7章 市場分析:地域別

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の地域

第8章 競合情報

  • 主な市場戦略
  • 企業プロファイル
    • Beckman Coulter Inc.
    • F. Hoffmann-La Roche AG
    • Abbott Laboratories
    • Siemens Healthcare AG
    • LSI Medicine Corp.

第9章 調査プロセス

図表

LIST OF TABLES

List of Tables

  • TABLE 1. GLOBAL CREATINE KINASE MARKET, REPORT SCOPE
  • TABLE 2. GLOBAL CREATINE KINASE MARKET ESTIMATES & FORECASTS BY REGION 2017-2027 (USD MILLION)
  • TABLE 3. GLOBAL CREATINE KINASE MARKET ESTIMATES & FORECASTS BY TYPE 2017-2027 (USD MILLION)
  • TABLE 4. GLOBAL CREATINE KINASE MARKET ESTIMATES & FORECASTS BY APPLICATION 2017-2027 (USD MILLION)
  • TABLE 5. GLOBAL CREATINE KINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 6. GLOBAL CREATINE KINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 7. GLOBAL CREATINE KINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 8. GLOBAL CREATINE KINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 9. GLOBAL CREATINE KINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 10. GLOBAL CREATINE KINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 11. GLOBAL CREATINE KINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 12. GLOBAL CREATINE KINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 13. GLOBAL CREATINE KINASE MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 14. GLOBAL CREATINE KINASE MARKET BY REGION, ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 15. U.S. CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 16. U.S. CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 1. U.S. CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 2. CANADA CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 3. CANADA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 4. CANADA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 5. UK CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 6. UK CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 7. UK CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 8. GERMANY CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 9. GERMANY CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 10. GERMANY CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 11. ROE CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 12. ROE CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 13. ROE CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 14. CHINA CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 15. CHINA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 16. CHINA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 17. INDIA CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 18. INDIA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 19. INDIA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 20. JAPAN CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 21. JAPAN CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 22. JAPAN CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 23. ROAPAC CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 24. ROAPAC CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 25. ROAPAC CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 26. BRAZIL CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 27. BRAZIL CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 28. BRAZIL CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 29. MEXICO CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 30. MEXICO CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 31. MEXICO CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 32. ROLA CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 33. ROLA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 34. ROLA CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 35. ROW CREATINE KINASE MARKET ESTIMATES & FORECASTS, 2017-2027 (USD MILLION)
  • TABLE 36. ROW CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 37. ROW CREATINE KINASE MARKET ESTIMATES & FORECASTS BY SEGMENT 2017-2027 (USD MILLION)
  • TABLE 38. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CREATINE KINASE MARKET
  • TABLE 39. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CREATINE KINASE MARKET
  • TABLE 40. YEARS CONSIDERED FOR THE STUDY
  • TABLE 41. EXCHANGE RATES CONSIDERED

LIST OF FIGURES

List of Figures

  • FIG 1. GLOBAL CREATINE KINASE MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL CREATINE KINASE MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL CREATINE KINASE MARKET, KEY TRENDS 2019
  • FIG 5. GLOBAL CREATINE KINASE MARKET, GROWTH PROSPECTS 2020-2027
  • FIG 6. GLOBAL CREATINE KINASE MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL CREATINE KINASE MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL CREATINE KINASE MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL CREATINE KINASE MARKET BY SEGMENT, 2017 & 2027 (USD MILLION)
  • FIG 10. GLOBAL CREATINE KINASE MARKET BY SEGMENT, 2017 & 2027 (USD MILLION)
  • FIG 11. GLOBAL CREATINE KINASE MARKET BY SEGMENT, 2017 & 2027 (USD MILLION)
  • FIG 12. GLOBAL CREATINE KINASE MARKET BY SEGMENT, 2017 & 2027 (USD MILLION)
  • FIG 13. GLOBAL CREATINE KINASE MARKET BY SEGMENT, 2017 & 2027 (USD MILLION)
  • FIG 14. GLOBAL CREATINE KINASE MARKET, REGIONAL SNAPSHOT 2017 & 2027
  • FIG 15. NORTH AMERICA CREATINE KINASE MARKET 2017 & 2027 (USD MILLION)
  • FIG 16. EUROPE CREATINE KINASE MARKET 2017 & 2027 (USD MILLION)
  • FIG 17. ASIA PACIFIC CREATINE KINASE MARKET 2017 & 2027 (USD MILLION)
  • FIG 18. LATIN AMERICA CREATINE KINASE MARKET 2017 & 2027 (USD MILLION)
  • FIG 19. GLOBAL CREATINE KINASE MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
目次

Global Creatine Kinase Market is valued approximately at USD XXX million in 2019 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2020-2027. Creatine kinase (also referred as phosphocreatine kinase or creatine phosphokinase), is a protein enzyme, which is recognized through different types tissues and cell. Creatine kinase catalyzes the transformation of creatine and uses adenosine triphosphate (ATP) to produce phosphocreatine (PCr) and adenosine diphosphate (ADP). Creatine kinase enzyme reaction is revocable, and thus, ATP can be produced from ADP and PCr. It is usually found in skeletal muscles and heart and in smaller amounts in the brain. It works with bones to move and give strength and power to the individual's body. Growing patient population suffering from myocardial infarction, favorable reimbursement scenario and increasing healthcare expenditure & funding are the few factors responsible for high CAGR of the market over the forecast period. For instance, according to the Centers for Medicare & Medicaid Services (CMS), the national health expenditure was estimated around 4.8% in 2019, an increase from 4.4% growth in 2018, and to reach almost USD 3.8 trillion. Also, as per Statista, the public health expenditure in India was about 1.58 trillion Indian rupees in 2018. This factor would boost the demand for Creatine Kinase in the global market thereby, aiding to the market growth in the forthcoming years. Furthermore, rapid launch of novel creatine kinase reagents to enhance the creatine kinase testing is further contemplating the market growth around the world. With the disruption in product supply chain because of COVID-19 crisis, several leading suppliers are under lockdown to prevent the spread of novel coronavirus therefore, the industry is recently faced several significant challenges with concerns to ramping up the manufacturing facilities to reduce the risk of supply shortage. Thus, this factor is expected to create a major obstacle to market growth in the recent year. However, un favorable regulatory guideline for product approval in some of the developed and developing nations is always being considered as one of the major restraining factors to the market growth during the forecast period of 2020-2027.

The regional analysis of global Creatine Kinase market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the presence of strong and advanced healthcare facilities, coupled with increasing product launch of new creatine kinase reagents testing kits in the region. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027, due to growing healthcare expenditure in the countries such as China and India.

Major market player included in this report are:

Beckman Coulter Inc.

F. Hoffmann-La Roche AG

Abbott Laboratories

Siemens Healthcare AG

LSI Medicine Corp.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

MM

BB

MB

MiMi

By Application:

Hospital

Laboratory

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017, 2018

Base year - 2019

Forecast period - 2020 to 2026

Target Audience of the Global Creatine Kinase Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
    • 1.2.1. Creatine Kinase Market, by Region, 2018-2027 (USD Million)
    • 1.2.2. Creatine Kinase Market, by Type, 2018-2027 (USD Million)
    • 1.2.3. Creatine Kinase Market, by Application, 2018-2027 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Creatine Kinase Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Creatine Kinase Market Dynamics

  • 3.1. Creatine Kinase Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Creatine Kinase Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Creatine Kinase Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Creatine Kinase Market by Type, Performance - Potential Analysis
  • 5.3. Global Creatine Kinase Market Estimates & Forecasts by Type 2017-2027 (USD Million)
  • 5.4. Creatine Kinase Market, Sub Segment Analysis
    • 5.4.1. MM
    • 5.4.2. BB
    • 5.4.3. MB
    • 5.4.4. MiMi

Chapter 6. Global Creatine Kinase Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Creatine Kinase Market by Application, Performance - Potential Analysis
  • 6.3. Global Creatine Kinase Market Estimates & Forecasts by Application 2017-2027 (USD Million)
  • 6.4. Creatine Kinase Market, Sub Segment Analysis
    • 6.4.1. Hospital
    • 6.4.2. Laboratory
    • 6.4.3. Others

Chapter 7. Global Creatine Kinase Market, Regional Analysis

  • 7.1. Creatine Kinase Market, Regional Market Snapshot
  • 7.2. North America Creatine Kinase Market
    • 7.2.1. U.S. Creatine Kinase Market
      • 7.2.1.1. Type breakdown estimates & forecasts, 2017-2027
      • 7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
    • 7.2.2. Canada Creatine Kinase Market
  • 7.3. Europe Creatine Kinase Market Snapshot
    • 7.3.1. U.K. Creatine Kinase Market
    • 7.3.2. Germany Creatine Kinase Market
    • 7.3.3. Rest of Europe Creatine Kinase Market
  • 7.4. Asia-Pacific Creatine Kinase Market Snapshot
    • 7.4.1. China Creatine Kinase Market
    • 7.4.2. India Creatine Kinase Market
    • 7.4.3. Japan Creatine Kinase Market
    • 7.4.4. Rest of Asia Pacific Creatine Kinase Market
  • 7.5. Latin America Creatine Kinase Market Snapshot
    • 7.5.1. Brazil Creatine Kinase Market
    • 7.5.2. Mexico Creatine Kinase Market
  • 7.6. Rest of The World Creatine Kinase Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Beckman Coulter Inc.
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. F. Hoffmann-La Roche AG
    • 8.2.3. Abbott Laboratories
    • 8.2.4. Siemens Healthcare AG
    • 8.2.5. LSI Medicine Corp.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.